The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
iodine I 131
A radioactive isotope of iodine with an atomic mass of 131, a half life
of eight days, and potential antineoplastic activity. Selectively
accumulating in the thyroid gland, iodine I 131 emits beta and gamma
particles, thereby killing thyroid cells and decreasing thyroid hormone